Gilead Sciences, Inc. total revenue, net income and dynamics of changes in US dollar today
Gilead Sciences, Inc. current income and income for the latest reporting periods. Gilead Sciences, Inc. net revenue for today is 6 217 000 000 $. Net income, revenue and dynamics - the main financial indicators of Gilead Sciences, Inc.. Schedule of the financial report of Gilead Sciences, Inc. for today. The financial report schedule from 30/06/2017 to 30/06/2021 is available online. Gilead Sciences, Inc. total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
6 217 000 000 $
+9.36 % ↑
1 522 000 000 $
-19.0426 % ↓
31/03/2021
6 423 000 000 $
+21.62 % ↑
1 729 000 000 $
-12.456 % ↓
31/12/2020
7 421 000 000 $
+26.23 % ↑
1 551 000 000 $
-42.47 % ↓
30/09/2020
6 577 000 000 $
+17.36 % ↑
360 000 000 $
-
31/12/2019
5 879 000 000 $
-
2 696 000 000 $
-
30/09/2019
5 604 000 000 $
-
-1 165 000 000 $
-
30/06/2019
5 685 000 000 $
-
1 880 000 000 $
-
31/03/2019
5 281 000 000 $
-
1 975 000 000 $
-
31/12/2018
5 795 000 000 $
-
3 000 000 $
-
30/09/2018
5 596 000 000 $
-
2 097 000 000 $
-
30/06/2018
5 648 000 000 $
-
1 817 000 000 $
-
31/03/2018
5 088 000 000 $
-
1 538 000 000 $
-
31/12/2017
5 949 000 000 $
-
-3 865 000 000 $
-
30/09/2017
6 512 000 000 $
-
2 718 000 000 $
-
30/06/2017
7 141 000 000 $
-
3 073 000 000 $
-
Show:
to
Gilead Sciences, Inc. financial report charts
The dates of the latest financial statements of Gilead Sciences, Inc.: 30/06/2017, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Gilead Sciences, Inc. is 30/06/2021. Gross profit Gilead Sciences, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Gilead Sciences, Inc. is 4 827 000 000 $
Gilead Sciences, Inc. quarterly report dates
Cost of revenue Gilead Sciences, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Gilead Sciences, Inc. is 1 390 000 000 $ Total revenue Gilead Sciences, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Gilead Sciences, Inc. is 6 217 000 000 $ Operating income Gilead Sciences, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Gilead Sciences, Inc. is 2 342 000 000 $
Net income Gilead Sciences, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Gilead Sciences, Inc. is 1 522 000 000 $ Current assets Gilead Sciences, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Gilead Sciences, Inc. is 14 498 000 000 $ Total assets Gilead Sciences, Inc. refers to the total amount of assets owned by a person or entity. Total assets Gilead Sciences, Inc. is 67 984 000 000 $
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
4 827 000 000 $
5 062 000 000 $
6 904 000 000 $
5 436 000 000 $
4 196 000 000 $
4 569 000 000 $
4 685 000 000 $
4 324 000 000 $
4 225 000 000 $
4 510 000 000 $
4 452 000 000 $
4 087 000 000 $
4 693 000 000 $
5 480 000 000 $
6 015 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 390 000 000 $
1 361 000 000 $
517 000 000 $
1 141 000 000 $
1 683 000 000 $
1 035 000 000 $
1 000 000 000 $
957 000 000 $
1 570 000 000 $
1 086 000 000 $
1 196 000 000 $
1 001 000 000 $
1 256 000 000 $
1 032 000 000 $
1 126 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
6 217 000 000 $
6 423 000 000 $
7 421 000 000 $
6 577 000 000 $
5 879 000 000 $
5 604 000 000 $
5 685 000 000 $
5 281 000 000 $
5 795 000 000 $
5 596 000 000 $
5 648 000 000 $
5 088 000 000 $
5 949 000 000 $
6 512 000 000 $
7 141 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
5 879 000 000 $
5 604 000 000 $
5 685 000 000 $
5 281 000 000 $
5 795 000 000 $
5 596 000 000 $
5 648 000 000 $
5 001 000 000 $
5 837 000 000 $
6 402 000 000 $
7 046 000 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
2 342 000 000 $
2 963 000 000 $
3 916 000 000 $
3 172 000 000 $
1 889 000 000 $
-1 473 000 000 $
2 430 000 000 $
2 237 000 000 $
1 964 000 000 $
2 623 000 000 $
2 280 000 000 $
2 153 000 000 $
2 291 000 000 $
3 812 000 000 $
4 254 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 522 000 000 $
1 729 000 000 $
1 551 000 000 $
360 000 000 $
2 696 000 000 $
-1 165 000 000 $
1 880 000 000 $
1 975 000 000 $
3 000 000 $
2 097 000 000 $
1 817 000 000 $
1 538 000 000 $
-3 865 000 000 $
2 718 000 000 $
3 073 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 134 000 000 $
1 055 000 000 $
1 412 000 000 $
1 158 000 000 $
1 103 000 000 $
4 990 000 000 $
1 160 000 000 $
1 057 000 000 $
1 130 000 000 $
939 000 000 $
1 192 000 000 $
937 000 000 $
1 150 000 000 $
789 000 000 $
864 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
3 875 000 000 $
3 460 000 000 $
3 505 000 000 $
3 405 000 000 $
3 990 000 000 $
7 077 000 000 $
3 255 000 000 $
3 044 000 000 $
3 831 000 000 $
2 973 000 000 $
3 368 000 000 $
1 934 000 000 $
2 402 000 000 $
1 668 000 000 $
1 761 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
14 498 000 000 $
13 278 000 000 $
15 996 000 000 $
30 926 000 000 $
31 489 000 000 $
28 361 000 000 $
33 727 000 000 $
34 024 000 000 $
35 836 000 000 $
34 918 000 000 $
32 728 000 000 $
30 258 000 000 $
31 823 000 000 $
35 317 000 000 $
28 592 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
67 984 000 000 $
67 492 000 000 $
68 407 000 000 $
60 878 000 000 $
61 627 000 000 $
59 146 000 000 $
63 210 000 000 $
62 837 000 000 $
63 675 000 000 $
64 305 000 000 $
65 355 000 000 $
65 381 000 000 $
70 283 000 000 $
64 662 000 000 $
60 263 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
7 361 000 000 $
4 065 000 000 $
5 997 000 000 $
12 886 000 000 $
25 840 000 000 $
9 474 000 000 $
11 240 000 000 $
16 927 000 000 $
17 940 000 000 $
14 569 000 000 $
13 234 000 000 $
7 643 000 000 $
7 588 000 000 $
11 508 000 000 $
8 712 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
9 759 000 000 $
9 567 000 000 $
8 961 000 000 $
9 397 000 000 $
10 605 000 000 $
10 116 000 000 $
10 912 000 000 $
2 497 000 000 $
2 747 000 000 $
1 747 000 000 $
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
23 998 000 000 $
25 510 000 000 $
28 387 000 000 $
21 096 000 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
38 977 000 000 $
38 410 000 000 $
40 459 000 000 $
40 746 000 000 $
42 141 000 000 $
41 298 000 000 $
43 621 000 000 $
29 054 000 000 $
33 542 000 000 $
29 262 000 000 $
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
63.25 %
64.94 %
64.01 %
64.84 %
66.18 %
64.22 %
66.74 %
44.44 %
47.72 %
45.25 %
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
19 710 000 000 $
18 952 000 000 $
18 202 000 000 $
17 445 000 000 $
22 650 000 000 $
20 604 000 000 $
22 616 000 000 $
21 951 000 000 $
21 387 000 000 $
22 861 000 000 $
21 672 000 000 $
20 591 000 000 $
20 442 000 000 $
24 845 000 000 $
22 677 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
2 899 000 000 $
2 221 000 000 $
1 444 000 000 $
2 345 000 000 $
2 212 000 000 $
1 573 000 000 $
2 270 000 000 $
2 753 000 000 $
2 694 000 000 $
3 526 000 000 $
Last revenue report of Gilead Sciences, Inc. was 30/06/2021. According to last financial report total revenue in Gilead Sciences, Inc. was 6 217 000 000 US dollar and changed by +9.36% since last year. Net income in Gilead Sciences, Inc. was 1 522 000 000 $ in last quartal, net income changes to -19.0426%.
Current cash Gilead Sciences, Inc. - the sum of all of the cash a company has on the date of report. Current cash Gilead Sciences, Inc. is 7 361 000 000 $
Gilead Sciences, Inc. stocks data
GILD stock price
Gilead Sciences, Inc. stock price today, GILD stock quote.
